Recognition of Non-Operating Income and Expenses
CanBas Co.,Ltd.
Interest income consists of interest on the company's deposits. The foreign exchange loss resulted from fluctuations in exchange rates for foreign-currency-denominated accounts payable related to clinical trial preparation expenses and other items, and foreign-currency-denominated deposits.
Non-operating income: interest income of ¥1,760 thousand; non-operating expenses: foreign exchange loss of ¥16,801 thousand
First quarter of the fiscal year ending June 2027 (1 July 2026–30 September 2026)
This matter is reflected in the "Summary of Financial Results for the First Quarter of the Fiscal Year Ending June 2027 [Japanese GAAP] (Non-consolidated)" released today.
This matter is reflected in the "Summary of Financial Results for the First Quarter of the Fiscal Year Ending June 2027 [Japanese GAAP] (Non-consolidated)" released today.
| Item | Details |
|---|---|
| Event name | Recognition of Non-Operating Income and Expenses |
| Date of occurrence | 1 July 2026–30 September 2026 (first quarter of the fiscal year ending June 2027) |
| Subject Entity | CanBas Co.,Ltd. |
| Cause | Interest income consists of interest on the company's deposits. The foreign exchange loss resulted from fluctuations in exchange rates for foreign-currency-denominated accounts payable related to clinical trial preparation expenses and other items, and foreign-currency-denominated deposits. |
| Amount of Impact on Business Performance | Non-operating income: interest income of ¥1,760 thousand; non-operating expenses: foreign exchange loss of ¥16,801 thousand |
| Accounting period in which recognized | First quarter of the fiscal year ending June 2027 (1 July 2026–30 September 2026) |
| Impact on Earnings Forecast | This matter is reflected in the "Summary of Financial Results for the First Quarter of the Fiscal Year Ending June 2027 [Japanese GAAP] (Non-consolidated)" released today. |
| Outlook | This matter is reflected in the "Summary of Financial Results for the First Quarter of the Fiscal Year Ending June 2027 [Japanese GAAP] (Non-consolidated)" released today. |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Interest income consists of interest on the company's deposits. The foreign exchange loss resulted from fluctuations in exchange rates for foreign-currency-denominated accounts payable related to clinical trial preparation expenses and other items, as well as foreign-currency-denominated deposits.